About Zinc finger protein 292
Zinc finger protein 292 (ZNF292) is a protein
from Homo sapiens identified by UniProt accession
O60281, 2723 residues long.
MolForge cross-references it against 0 known binders and
104 disease associations.
Target properties
| Protein name | Zinc finger protein 292 |
|---|
| UniProt accession | O60281 |
|---|
| Gene | ZNF292 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 2723 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
3D Structure (8)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
Amino-acid sequence (2723 residues)
MADEEAEQER LSCGEGGCVA ELQRLGERLQ ELELQLRESR VPAVEAATDY CQQLCQTLLE YAEKWKTSED PLPLLEVYTV AIQSYVKARP YLTSECENVA LVLERLALSC VELLLCLPVE LSDKQWEQFQ TLVQVAHEKL MENGSCELHF LATLAQETGV WKNPVLCTIL SQEPLDKDKV NEFLAFEGPI LLDMRIKHLI KTNQLSQATA LAKLCSDHPE IGIKGSFKQT YLVCLCTSSP NGKLIEEISE VDCKDALEMI CNLESEGDEK SALVLCTAFL SRQLQQGDMY CAWELTLFWS KLQQRVEPSI QVYLERCRQL SLLTKTVYHI FFLIKVINSE TEGAGLATCI ELCVKALRLE STENTEVKIS ICKTISCLLP DDLEVKRACQ LSEFLIEPTV DAYYAVEMLY NQPDQKYDEE NLPIPNSLRC ELLLVLKTQW PFDPEFWDWK TLKRQCLALM GEEASIVSSI DELNDSEVYE KVVDYQEESK ETSMNGLSGG VGANSGLLKD IGDEKQKKRE IKQLRERGFI SARFRNWQAY MQYCVLCDKE FLGHRIVRHA QKHYKDGIYS CPICAKNFNS KETFVPHVTL HVKQSSKERL AAMKPLRRLG RPPKITTTNE NQKTNTVAKQ EQRPIKKNSL YSTDFIVFND NDGSDDENDD KDKSYEPEVI PVQKPVPVNE FNCPVTFCKK GFKYFKNLIA HVKGHKDNED AKRFLEMQSK KVICQYCRRH FVSVTHLNDH LQMHCGSKPY ICIQMKCKAG FNSYAELLTH RKEHQVFRAK CMFPKCGRIF SEAYLLYDHE AQHYNTYTCK FTGCGKVYRS QGELEKHLDD HSTPPEKVLP PEAQLNSSGD SIQPSEVNQN TAENIEKERS MLPSENNIEN SLLADRSDAW DKSKAESAVT KQDQISASEL RQANGPLSNG LENPATTPLL QSSEVAVSIK VSLNQGIEDN FGKQENSTVE GSGEALVTDL HTPVEDTCND LCHPGFQERK EQDCFNDAHV TQNSLVNSET LKIGDLTPQN LERQVNNLMT FSVQNQAAFQ NNLPTSKFEC GDNVKTSSNL YNLPLKTLES IAFVPPQSDL SNSLGTPSVP PKAPVQKFSC QVEGCTRTYN SSQSIGKHMK TAHPDQYAAF KMQRKSKKGQ KANNLNTPNN GKFVYFLPSP VNSSNPFFTS QTKANGNPAC SAQLQHVSPP IFPAHLASVS TPLLSSMESV INPNITSQDK NEQGGMLCSQ MENLPSTALP AQMEDLTKTV LPLNIDSGSD PFLPLPAESS SMSLFPSPAD SGTNSVFSQL ENNTNHYSSQ IEGNTNSSFL KGGNGENAVF PSQVNVANNF SSTNAQQSAP EKVKKDRGRG PNGKERKPKH NKRAKWPAII RDGKFICSRC YRAFTNPRSL GGHLSKRSYC KPLDGAEIAQ ELLQSNGQPS LLASMILSTN AVNLQQPQQS TFNPEACFKD PSFLQLLAEN RSPAFLPNTF PRSGVTNFNT SVSQEGSEII KQALETAGIP STFEGAEMLS HVSTGCVSDA SQVNATVMPN PTVPPLLHTV CHPNTLLTNQ NRTSNSKTSS IEECSSLPVF PTNDLLLKTV ENGLCSSSFP NSGGPSQNFT SNSSRVSVIS GPQNTRSSHL NKKGNSASKR RKKVAPPLIA PNASQNLVTS DLTTMGLIAK SVEIPTTNLH SNVIPTCEPQ SLVENLTQKL NNVNNQLFMT DVKENFKTSL ESHTVLAPLT LKTENGDSQM MALNSCTTSI NSDLQISEDN VIQNFEKTLE IIKTAMNSQI LEVKSGSQGA GETSQNAQIN YNIQLPSVNT VQNNKLPDSS PFSSFISVMP TKSNIPQSEV SHKEDQIQEI LEGLQKLKLE NDLSTPASQC VLINTSVTLT PTPVKSTADI TVIQPVSEMI NIQFNDKVNK PFVCQNQGCN YSAMTKDALF KHYGKIHQYT PEMILEIKKN QLKFAPFKCV VPTCTKTFTR NSNLRAHCQL VHHFTTEEMV KLKIKRPYGR KSQSENVPAS RSTQVKKQLA MTEENKKESQ PALELRAETQ NTHSNVAVIP EKQLVEKKSP DKTESSLQVI TVTSEQCNTN ALTNTQTKGR KIRRHKKEKE EKKRKKPVSQ SLEFPTRYSP YRPYRCVHQG CFAAFTIQQN LILHYQAVHK SDLPAFSAEV EEESEAGKES EETETKQTLK EFRCQVSDCS RIFQAITGLI QHYMKLHEMT PEEIESMTAS VDVGKFPCDQ LECKSSFTTY LNYVVHLEAD HGIGLRASKT EEDGVYKCDC EGCDRIYATR SNLLRHIFNK HNDKHKAHLI RPRRLTPGQE NMSSKANQEK SKSKHRGTKH SRCGKEGIKM PKTKRKKKNN LENKNAKIVQ IEENKPYSLK RGKHVYSIKA RNDALSECTS RFVTQYPCMI KGCTSVVTSE SNIIRHYKCH KLSKAFTSQH RNLLIVFKRC CNSQVKETSE QEGAKNDVKD SDTCVSESND NSRTTATVSQ KEVEKNEKDE MDELTELFIT KLINEDSTSV ETQANTSSNV SNDFQEDNLC QSERQKASNL KRVNKEKNVS QNKKRKVEKA EPASAAELSS VRKEEETAVA IQTIEEHPAS FDWSSFKPMG FEVSFLKFLE ESAVKQKKNT DKDHPNTGNK KGSHSNSRKN IDKTAVTSGN HVCPCKESET FVQFANPSQL QCSDNVKIVL DKNLKDCTEL VLKQLQEMKP TVSLKKLEVH SNDPDMSVMK DISIGKATGR GQY
Explore Zinc finger protein 292 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets